U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults

BOTOX® is the First and Only FDA-Approved Neurotoxin Treatment for Both Upper and Lower Limb Spasticity DUBLIN, Jan. 22, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company today announced t... Biopharmaceuticals, FDAAllergan, BOTOX, botulinum toxin, spasticity
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news